News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: jbainseky post# 261033

Wednesday, 04/06/2016 6:43:34 PM

Wednesday, April 06, 2016 6:43:34 PM

Post# of 347009
I'll have to disagree and will back CP in this case, because it was told at NYAS as Dr. Brekken CONFIRMED the results were yes, better than initially reported.

Did they lie about the initial results? NO.... but since it was part of sabotage and just for that time being they had to file with the SEC to begin phase III Sunrise and the quickest way at that time was combine the two arms (Docetaxel+Placebo and the Docetaxel + 1mg Bavi ) vs the 3mg Bavituximab + Docetaxel arm

60% MOS improvement between this 3mg Bavi +Doce arm vs the combined other arms (part of the sabotage ...) would have been MUCH higher and again, this was CONFIRMED by Dr. Brekken at NYAS as he glanced to the back room looking for the LEGAL ok to publicly say so


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y